Literature DB >> 34015400

Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy.

Zahid Hussain1, Muhammad Abdur Rahim2, Nasrullah Jan2, Hassan Shah2, Mutasem Rawas-Qalaji3, Shahzeb Khan4, Mohammad Sohail5, Hnin Ei Thu6, Nor Amlizan Ramli7, Rai Muhammad Sarfraz8, Mohammed A S Abourehab9.   

Abstract

Despite enormous advancements in the field of oncology, the innocuous and effectual treatment of various types of malignancies remained a colossal challenge. The conventional modalities such as chemotherapy, radiotherapy, and surgery have been remained the most viable options for cancer treatment, but lacking of target-specificity, optimum safety and efficacy, and pharmacokinetic disparities are their impliable shortcomings. Though, in recent decades, numerous encroachments in the field of onco-targeted drug delivery have been adapted but several limitations (i.e., short plasma half-life, early clearance by reticuloendothelial system, immunogenicity, inadequate internalization and localization into the onco-tissues, chemoresistance, and deficient therapeutic efficacy) associated with these onco-targeted delivery systems limits their clinical viability. To abolish the aforementioned inadequacies, a promising approach has been emerged in which stealthing of synthetic nanocarriers has been attained by cloaking them into the natural cell membranes. These biomimetic nanomedicines not only retain characteristics features of the synthetic nanocarriers but also inherit the cell-membrane intrinsic functionalities. In this review, we have summarized preparation methods, mechanism of cloaking, and pharmaceutical and therapeutic superiority of cell-membrane camouflaged nanomedicines in improving the bio-imaging and immunotherapy against various types of malignancies. These pliable adaptations have revolutionized the current drug delivery strategies by optimizing the plasma circulation time, improving the permeation into the cancerous microenvironment, escaping the immune evasion and rapid clearance from the systemic circulation, minimizing the immunogenicity, and enabling the cell-cell communication via cell membrane markers of biomimetic nanomedicines. Moreover, the preeminence of cell-membrane cloaked nanomedicines in improving the bio-imaging and theranostic applications, alone or in combination with phototherapy or radiotherapy, have also been pondered.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Bio-imaging and anticancer efficacy; Biomimetic nanomedicines; Cell-membrane cloaking; Immunogenicity; Opsonization and plasma clearance; Overcoming chemoresistance

Year:  2021        PMID: 34015400     DOI: 10.1016/j.jconrel.2021.05.018

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  6 in total

Review 1.  Alginate as a Promising Biopolymer in Drug Delivery and Wound Healing: A Review of the State-of-the-Art.

Authors:  Mohammad A S Abourehab; Rahul R Rajendran; Anshul Singh; Sheersha Pramanik; Prachi Shrivastav; Mohammad Javed Ansari; Ravi Manne; Larissa Souza Amaral; A Deepak
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

Review 2.  Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders.

Authors:  Abdul Waris; Asmat Ali; Atta Ullah Khan; Muhammad Asim; Doaa Zamel; Kinza Fatima; Abdur Raziq; Muhammad Ajmal Khan; Nazia Akbar; Abdul Baset; Mohammed A S Abourehab
Journal:  Nanomaterials (Basel)       Date:  2022-06-22       Impact factor: 5.719

3.  Developed meloxicam loaded microparticles for colon targeted delivery: Statistical optimization, physicochemical characterization, and in-vivo toxicity study.

Authors:  Syed Abdul Wasay; Syed Umer Jan; Muhammad Akhtar; Sobia Noreen; Rahman Gul
Journal:  PLoS One       Date:  2022-04-25       Impact factor: 3.752

Review 4.  Dostarlimab as a Miracle Drug: Rising Hope against Cancer Treatment.

Authors:  Vanshikha Singh; Afsana Sheikh; Mohammed A S Abourehab; Prashant Kesharwani
Journal:  Biosensors (Basel)       Date:  2022-08-08

5.  Biodistribution Study of Niosomes in Tumor-Implanted BALB/C Mice Using Scintigraphic Imaging.

Authors:  Leanne De Silva; Ju-Yen Fu; Thet Thet Htar; Wan Hamirul Bahrin Wan Kamal; Azahari Kasbollah; Saravanan Muniyandy; Lay-Hong Chuah
Journal:  Front Pharmacol       Date:  2022-01-07       Impact factor: 5.810

6.  pH-Responsive Liposomes of Dioleoyl Phosphatidylethanolamine and Cholesteryl Hemisuccinate for the Enhanced Anticancer Efficacy of Cisplatin.

Authors:  Hassan Shah; Asadullah Madni; Muhammad Muzamil Khan; Fiaz-Ud-Din Ahmad; Nasrullah Jan; Safiullah Khan; Muhammad Abdur Rahim; Shahzeb Khan; Meser M Ali; Mohsin Kazi
Journal:  Pharmaceutics       Date:  2022-01-05       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.